Stephen J Turner Selected Research

deoxythymidine 3',5'-bis-(p-nitrophenyl phosphate)

12/2010	Influenza epitope-specific CD8+ T cell avidity, but not cytokine polyfunctionality, can be determined by TCRβ clonotype.
9/2010	Fixing an irrelevant TCR alpha chain reveals the importance of TCR beta diversity for optimal TCR alpha beta pairing and function of virus-specific CD8+ T cells.
12/2008	Complete modification of TCR specificity and repertoire selection does not perturb a CD8+ T cell immunodominance hierarchy.
8/2008	Terminal deoxynucleotidyltransferase is required for the establishment of private virus-specific CD8+ TCR repertoires and facilitates optimal CTL responses.
6/2008	Homogenization of TCR repertoires within secondary CD62Lhigh and CD62Llow virus-specific CD8+ T cell populations.
6/2006	Early establishment of diverse T cell receptor profiles for influenza-specific CD8(+)CD62L(hi) memory T cells.
1/2006	A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies.
4/2005	Effector CD8+ T cells recovered from an influenza pneumonia differentiate to a state of focused gene expression.
5/2004	Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity.
3/2004	Differential tumor necrosis factor receptor 2-mediated editing of virus-specific CD8+ effector T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen J Turner Research Topics

Disease

48	Infections 05/2022 - 08/2003
33	Human Influenza (Influenza) 11/2021 - 06/2003
7	Virus Diseases (Viral Diseases) 01/2022 - 08/2007
7	Inflammation (Inflammations) 01/2018 - 10/2000
2	Hypersensitivity (Allergy) 11/2020 - 12/2006
2	Coinfection 11/2009 - 08/2003
2	Pneumonia (Pneumonitis) 07/2008 - 03/2004
2	Obesity 09/2007 - 10/2004
2	Pediatric Obesity 09/2007 - 04/2007
2	Insulin Resistance 04/2007 - 01/2006
1	Type I Syndactyly 01/2022
1	Malaria 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019
1	Reinfection 01/2019
1	Arthritis (Polyarthritis) 01/2016
1	Pain (Aches) 01/2016
1	Tuberculosis (Tuberculoses) 03/2015
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2014
1	Neoplasms (Cancer) 12/2010
1	Weight Loss (Weight Reduction) 07/2008
1	Rotavirus Infections 01/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2007

Drug/Important Bio-Agent (IBA)

23	EpitopesIBA 01/2020 - 08/2003
11	AntigensIBA 01/2019 - 06/2004
10	deoxythymidine 3',5'-bis-(p-nitrophenyl phosphate)IBA 12/2010 - 03/2004
9	VaccinesIBA 01/2020 - 09/2007
9	Peptides (Polypeptides)IBA 01/2020 - 08/2003
8	CytokinesIBA 11/2021 - 05/2004
8	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2016 - 03/2004
7	AcidsIBA 06/2011 - 06/2003
6	LipopeptidesIBA 10/2015 - 03/2006
6	NucleoproteinsIBA 02/2007 - 06/2003
4	ChromatinIBA 01/2022 - 02/2016
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2011
3	RNA (Ribonucleic Acid)IBA 01/2019 - 10/2008
3	Granzymes (Granzyme)IBA 05/2009 - 10/2000
3	LipidsIBA 09/2007 - 01/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2007 - 08/2002
2	GlycolipidsIBA 01/2020 - 11/2017
2	Antiviral Agents (Antivirals)IBA 01/2019 - 10/2015
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018 - 01/2016
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 03/2015 - 11/2009
2	Neuraminidase (Sialidase)IBA 01/2015 - 08/2011
2	Bromodeoxyuridine (BrdU)IBA 01/2013 - 07/2012
2	Arginine (L-Arginine)FDA Link 03/2010 - 04/2005
2	Amino Acids FDA Link 01/2006 - 04/2005
2	Glycoproteins (Glycoprotein)IBA 01/2006 - 03/2004
1	Viral ProteinsIBA 05/2022
1	RNA Splice SitesIBA 01/2022
1	Deoxyribonucleases (DNase)FDA Link 11/2020
1	Transcription Factors (Transcription Factor)IBA 11/2020
1	RezafunginIBA 01/2020
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2020
1	InterferonsIBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2019
1	Macrophage Colony-Stimulating FactorIBA 01/2018
1	Protein Subunit VaccinesIBA 11/2017
1	Interleukin-4 (Interleukin 4)IBA 02/2016
1	Interleukin-15 (Interleukin 15)IBA 01/2016
1	ChemokinesIBA 01/2016
1	Detergents (Detergent)IBA 10/2015
1	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2015
1	BCG Vaccine FDA Link 03/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	Oseltamivir (Tamiflu)FDA Link 01/2015
1	Histones (Histone)IBA 11/2014
1	Freund's AdjuvantIBA 04/2014
1	Aluminum Hydroxide (Algeldrate)FDA Link 04/2014
1	aluminum sulfate (alum)IBA 04/2014
1	CD40 Ligand (CD40L)IBA 01/2013
1	Histocompatibility Antigens Class IIBA 12/2010
1	SolventsIBA 08/2010
1	Interferon Type IIBA 07/2010
1	HLA-B44 AntigenIBA 03/2010
1	Fumigant 93 (D-D)IBA 11/2009
1	Alanine (L-Alanine)FDA Link 12/2008
1	DNA (Deoxyribonucleic Acid)IBA 10/2008
1	Hemagglutinins (Hemagglutinin)IBA 10/2008
1	PerforinIBA 09/2008
1	GelatinasesIBA 07/2008
1	SmokeIBA 07/2008
1	CollagenIBA 01/2008
1	IntegrinsIBA 01/2008
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2007
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2007
1	Interleukin-2 (IL2)IBA 08/2007
1	Interferon gamma ReceptorIBA 06/2007
1	Nonesterified Fatty Acids (NEFA)IBA 04/2007
1	Oleic Acid (Oleate)IBA 04/2007
1	CeramidesIBA 04/2007
1	PalmitatesIBA 04/2007
1	AdiponectinIBA 01/2006
1	Triglycerides (Triacylglycerol)IBA 10/2004
1	Fish OilsIBA 10/2004
1	Indicators and Reagents (Reagents)IBA 06/2004
1	Type II Tumor Necrosis Factor ReceptorsIBA 03/2004

Therapy/Procedure

1	Therapeutics 01/2015
1	Transplantation 12/2006